-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Initiates Coverage On Tango Therapeutics with Outperform Rating, Announces Price Target of $19

Benzinga·02/23/2026 18:03:47
Listen to the news
Mizuho analyst Joseph Catanzaro initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Outperform rating and announces Price Target of $19.